Sharma, V.K.; Menis, S.; Brower, E.T.; Sayeed, E.; Ackland, J.; Lombardo, A.; Cottrell, C.A.; Torres, J.L.; Hassell, T.; Ward, A.B.;
et al. Use of Transient Transfection for cGMP Manufacturing of eOD-GT8 60mer, a Self-Assembling Nanoparticle Germline-Targeting HIV-1 Vaccine Candidate. Pharmaceutics 2024, 16, 742.
https://doi.org/10.3390/pharmaceutics16060742
AMA Style
Sharma VK, Menis S, Brower ET, Sayeed E, Ackland J, Lombardo A, Cottrell CA, Torres JL, Hassell T, Ward AB,
et al. Use of Transient Transfection for cGMP Manufacturing of eOD-GT8 60mer, a Self-Assembling Nanoparticle Germline-Targeting HIV-1 Vaccine Candidate. Pharmaceutics. 2024; 16(6):742.
https://doi.org/10.3390/pharmaceutics16060742
Chicago/Turabian Style
Sharma, Vaneet K., Sergey Menis, Evan T. Brower, Eddy Sayeed, Jim Ackland, Angela Lombardo, Christopher A. Cottrell, Jonathan L. Torres, Thomas Hassell, Andrew B. Ward,
and et al. 2024. "Use of Transient Transfection for cGMP Manufacturing of eOD-GT8 60mer, a Self-Assembling Nanoparticle Germline-Targeting HIV-1 Vaccine Candidate" Pharmaceutics 16, no. 6: 742.
https://doi.org/10.3390/pharmaceutics16060742
APA Style
Sharma, V. K., Menis, S., Brower, E. T., Sayeed, E., Ackland, J., Lombardo, A., Cottrell, C. A., Torres, J. L., Hassell, T., Ward, A. B., Tsvetnitsky, V., & Schief, W. R.
(2024). Use of Transient Transfection for cGMP Manufacturing of eOD-GT8 60mer, a Self-Assembling Nanoparticle Germline-Targeting HIV-1 Vaccine Candidate. Pharmaceutics, 16(6), 742.
https://doi.org/10.3390/pharmaceutics16060742
